Show
Sort by
-
Paracellular entry of interleukin-10 producing Lactococcus lactis in inflamed intestinal mucosa in mice
-
Agalactosyl immunoglobulins are a useful marker for clinical progression and successful therapy of collagen-induced arthritis
-
CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease
-
Downregulation of metallothioneins (MTS) in intestinal epithelial cells (IECs) is associated with impaired chemoattractant activity
-
Induction of antigen-specific oral tolerance by genetically modified Lactococcus lactis delivering DQ8-specific immunodominant gliadin epitopes to gluten-sensitized class II transgenic mice
-
Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered antigen
-
Intestinal secretion of murine trefoil factor 3 via orally administered L-Lactis shows strong therapeutic effect in 5-fluorouracil induced mucositis
-
Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin
-
Murine trefoil factor 3 does not directly modulate LPS-mediated dendritic cell function
-
Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis
-
Clinical potential of Lactococcus lactis mediated delivery of human Interleukin-10 and Trefoil Factors
-
Altered gut transcriptome in spondyloarthropathy
-
Intracellular accumulation of trehalose protects Lactococcus lactis from freeze-drying damage and bile toxicity and increases gastric acid resistance
-
Therapeutic drug delivery by genetically modified Lactococcus lactis
-
Mucosal delivery of ovalbumin by the genetically modified Lactocossus lactis suppresses T cell responses in DO11.10 mice